Session

Oesophageal, gastric and duodenal disorders (Posters)

GASTRIC CANCER MISSED IN A WELL-DEFINED SPANISH POPULATION
GASTRIC CANCER MISSED IN A WELL-DEFINED SPANISH POPULATION

Oesophageal, gastric and duodenal disorders (Posters)  et al.

LCI IMPROVES THE VISIBILITY OF MINIMAL CHANGE ESOPHAGITIS- A LAB COLOR VALUE BASED QUANTITATIVE ANALYSIS
LCI IMPROVES THE VISIBILITY OF MINIMAL CHANGE ESOPHAGITIS- A LAB COLOR VALUE BASED QUANTITATIVE ANALYSIS

Oesophageal, gastric and duodenal disorders (Posters)  et al.

TOLERANCE TO STERILIZED COW’S MILK IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS TRIGGERED BY MILK
TOLERANCE TO STERILIZED COW’S MILK IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS TRIGGERED BY MILK

Oesophageal, gastric and duodenal disorders (Posters)  et al.

RNA SEQUENCING REVEALS FEW MOLECULAR DIFFERENCES IN OESOPHAGEAL MUCOSA BETWEEN PATIENTS WITH EROSIVE AND NON-EROSIVE REFLUX DISEASE
RNA SEQUENCING REVEALS FEW MOLECULAR DIFFERENCES IN OESOPHAGEAL MUCOSA BETWEEN PATIENTS WITH EROSIVE AND NON-EROSIVE REFLUX DISEASE

Oesophageal, gastric and duodenal disorders (Posters)  et al.

USE OF MUCOLYTIC SOLUTION BEFORE GASTROSCOPY – A DOUBLE-BLIND, RANDOMIZED STUDY
USE OF MUCOLYTIC SOLUTION BEFORE GASTROSCOPY – A DOUBLE-BLIND, RANDOMIZED STUDY

Oesophageal, gastric and duodenal disorders (Posters)  et al.

MALT LYMPHOMA A LONG-TERM FOLLOW-UP FROM A SINGLE CENTER EXPERIENCE
MALT LYMPHOMA A LONG-TERM FOLLOW-UP FROM A SINGLE CENTER EXPERIENCE

Oesophageal, gastric and duodenal disorders (Posters)  et al.

RANDOMIZED CLINICAL TRIAL: EFFICACY AND SAFETY OF FEXUPRAZAN IN PATIENTS WITH ACUTE OR CHRONIC GASTRITIS
RANDOMIZED CLINICAL TRIAL: EFFICACY AND SAFETY OF FEXUPRAZAN IN PATIENTS WITH ACUTE OR CHRONIC GASTRITIS

Oesophageal, gastric and duodenal disorders (Posters)  et al.

PREVALENCE OF DELAYED GASTRIC EMPTYING IN DIABETIC PATIENTS WITH GASTROPARESIS-LIKE SYMPTOMS
PREVALENCE OF DELAYED GASTRIC EMPTYING IN DIABETIC PATIENTS WITH GASTROPARESIS-LIKE SYMPTOMS

Oesophageal, gastric and duodenal disorders (Posters)  et al.

BLUE LIGHT IMAGING AND LINKED COLOR IMAGING AS A SCREENING MODE FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA IN HIGH-RISK PATIENTS: A MULTICENTRE RANDOMIZED CONTROLLED TRIAL
BLUE LIGHT IMAGING AND LINKED COLOR IMAGING AS A SCREENING MODE FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA IN HIGH-RISK PATIENTS: A MULTICENTRE RANDOMIZED CONTROLLED TRIAL

Oesophageal, gastric and duodenal disorders (Posters)  et al.

VONOPRAZAN OR MORE THAN DOUBLE-DOSE PROTON PUMP INHIBITOR MAINTENANCE THERAPY SHOULD BE PERFORMED IN PATIENTS WITH SYSTEMIC SCLEROSIS WITH ABSENT CONTRACTILITY
VONOPRAZAN OR MORE THAN DOUBLE-DOSE PROTON PUMP INHIBITOR MAINTENANCE THERAPY SHOULD BE PERFORMED IN PATIENTS WITH SYSTEMIC SCLEROSIS WITH ABSENT CONTRACTILITY

Oesophageal, gastric and duodenal disorders (Posters)  et al.

TISSUE ADHESIVE POLYACRYLAMIDE HYDROGEL INCORPORATING TRIAMCINOLONE ACETONIDE IS EFFECTIVE FOR PREVENTION OF FIBROSIS IN RATS' ESOPHAGUS
TISSUE ADHESIVE POLYACRYLAMIDE HYDROGEL INCORPORATING TRIAMCINOLONE ACETONIDE IS EFFECTIVE FOR PREVENTION OF FIBROSIS IN RATS' ESOPHAGUS

Oesophageal, gastric and duodenal disorders (Posters)  et al.

DUAL ASSESSMENT OF GASTRIC FUNCTION WITH SIMULTANEOUS GASTRIC EMPTYING AND BODY-SURFACE GASTRIC MAPPING IN PATIENTS WITH GASTROPARESIS-LIKE SYMPTOM AND FUNCTIONAL DYSPEPSIA
DUAL ASSESSMENT OF GASTRIC FUNCTION WITH SIMULTANEOUS GASTRIC EMPTYING AND BODY-SURFACE GASTRIC MAPPING IN PATIENTS WITH GASTROPARESIS-LIKE SYMPTOM AND FUNCTIONAL DYSPEPSIA

Oesophageal, gastric and duodenal disorders (Posters)  et al.

USEFULNESS OF THE MODIFIED PRENDOSCOPIC ROCKALL INDEX TO PREDICT OUTCOMES IN UPPER GASTROINTESTINAL BLEEDING DUE TO PEPTIC ULCER
USEFULNESS OF THE MODIFIED PRENDOSCOPIC ROCKALL INDEX TO PREDICT OUTCOMES IN UPPER GASTROINTESTINAL BLEEDING DUE TO PEPTIC ULCER

Oesophageal, gastric and duodenal disorders (Posters)  et al.

CAN CONCOMITANT USE OF H2RA PLAY AN IMPORTANT ROLE IN PREVENTING THE GASTRIC MUCOSAL INJURIES LIKE P-CAB OR PPI IN PATIENTS TAKING ASPIRIN?
CAN CONCOMITANT USE OF H2RA PLAY AN IMPORTANT ROLE IN PREVENTING THE GASTRIC MUCOSAL INJURIES LIKE P-CAB OR PPI IN PATIENTS TAKING ASPIRIN?

Oesophageal, gastric and duodenal disorders (Posters)  et al.

VALIDATION OF A DSC SCORE AS SCREENING TEST FOR GASTRIC PRECANCEROUS LESIONS IN A NON-HIGH-INCIDENCE AREA
VALIDATION OF A DSC SCORE AS SCREENING TEST FOR GASTRIC PRECANCEROUS LESIONS IN A NON-HIGH-INCIDENCE AREA

Oesophageal, gastric and duodenal disorders (Posters)  et al.

HIATUS HERNIA: PREVALENCE, PRESENTATION AND EVALUATION OF ESOPHAGEAL SEQUELA
HIATUS HERNIA: PREVALENCE, PRESENTATION AND EVALUATION OF ESOPHAGEAL SEQUELA

Oesophageal, gastric and duodenal disorders (Posters)  et al.

EFFICACY AND SAFETY OF HIP1601 (DUAL DELAYED-RELEASE ESOMEPRAZOLE) 40MG IN EROSIVE ESOPHAGITIS COMPARED TO HGP1705 (DELAYED-RELEASE ESOMEPRAZOLE) 40MG: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, NON-INFERIORITY STUDY
EFFICACY AND SAFETY OF HIP1601 (DUAL DELAYED-RELEASE ESOMEPRAZOLE) 40MG IN EROSIVE ESOPHAGITIS COMPARED TO HGP1705 (DELAYED-RELEASE ESOMEPRAZOLE) 40MG: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, NON-INFERIORITY STUDY

Oesophageal, gastric and duodenal disorders (Posters)  et al.

A STUDY ON THE USEFULNESS OF LINKED COLOR IMAGING DEPENDING ON DOCTORS AND LESIONS USING EYE TRACKING
A STUDY ON THE USEFULNESS OF LINKED COLOR IMAGING DEPENDING ON DOCTORS AND LESIONS USING EYE TRACKING

Oesophageal, gastric and duodenal disorders (Posters)  et al.

CONFOCAL LASER ENDOMICROSCOPY (PCLE)DETECTS MUCOSAL NEOPLASTIC VASCULAR PATTERN IN GASTRIC LINITISPLASTICA
CONFOCAL LASER ENDOMICROSCOPY (PCLE)DETECTS MUCOSAL NEOPLASTIC VASCULAR PATTERN IN GASTRIC LINITISPLASTICA

Oesophageal, gastric and duodenal disorders (Posters)  et al.

THE NATURAL COURSE OF UNTREATED NEOPLASIA IN BARRETT’S ESOPHAGUS - A CASE-SERIES
THE NATURAL COURSE OF UNTREATED NEOPLASIA IN BARRETT’S ESOPHAGUS - A CASE-SERIES

Oesophageal, gastric and duodenal disorders (Posters)  et al.

Item 141 - 160 / 228
1 2 3 4 5 6 7
8
9 10 11 12